Search for: "Clayton v. Bristol-Myers Squibb Co."
Results 1 - 2
of 2
Sorted by Relevance
|
Sort by Date
7 Jul 2021, 11:44 pm
The two PTE applications This case concerned a patent owned jointly by Ono Pharmaceutical Co and E R Squibb & Sons, LLC (together, Patentees), titled “Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics”. [read post]
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
